Compound Detail

CHEMBL5091354

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C=CC1CN2CCC1C[C@H]2[C@@H](NC(=O)Nc1ccc(OC)cc1)c1ccnc2ccc(OC)cc12

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5091354
Phase	Preclinical
Structure Type	MOL
InChI Key	JELXXKILZYJQJI-BOOWZDDJSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

472.6

MW (Da)

5.01

ALogP

HBA

HBD

75.7

PSA (Å²)

0.47

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 5.23

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
Unchecked CHEMBL612545	IC50	5.23	5.23	5850.0	1
Mahlavu CHEMBL4296473	IC50	5.2	5.2	6290.0	1
HepG2 CHEMBL395	IC50	5.02	5.02	9550.0	1
Hep 3B2 CHEMBL4296437	IC50	5.0	5.0	9920.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
Unchecked	IC50	=	5850.0	nM	5.23	Cytotoxicity against mouse HCA1 cells assessed as cell viability by MTT assay	34558909
Mahlavu	IC50	=	6290.0	nM	5.2	Cytotoxicity against human Mahlavu cells assessed as cell viability by MTT assay	34558909
HepG2	IC50	=	9550.0	nM	5.02	Cytotoxicity against human HepG2 cells assessed as cell viability by MTT assay	34558909
Hep 3B2	IC50	=	9920.0	nM	5.0	Cytotoxicity against human Hep3B cells assessed as cell viability by MTT assay	34558909

PubMed	DOI	Target Context	# Activities
34558909	10.1021/acs.jmedchem.1c01036	Unchecked	3
34558909	10.1021/acs.jmedchem.1c01036	Mahlavu	1
34558909	10.1021/acs.jmedchem.1c01036	Hep 3B2	1
34558909	10.1021/acs.jmedchem.1c01036	HepG2	1

Data from ChEMBL 36 via Core Engine